Efficacy of Systemic Acyclovir as Adjuvant Therapy for Oral Lichen Planus

05 December 2021: Articles

Unusual setting of medical care

Dewi Zakiawati ^A* , Muhammad Al Farisyi ^A , Tenny Setiani Dewi ^A

DOI: 10.12659/AJCR.934554

Am J Case Rep 2021; 22:e934554

Table 1. Laboratory findings.

Test	Results		Reference value	Unit
Test	First visit	Third control	Reference value	Unit
Hemoglobin	11.1	9.9	14.0–17.4	g/dL
Erythrocyte	3.6	3.65	4.4–6	10/µl
Hematocrit	32.2	30.6	41.5–50.4	%
MCV	89.4	83.8	80–96	fL
MCH	30.8	27.1	27.5–33.2	Pg
MCHC	34.5	32.4	33.4–35.5	%
RDW-CV	–	14.9	11.5–14.5	%
RDW-SD	–	45	35.1–43.9	fL
Leucocyte	4720	3880	4400–11 300	/µl
Thrombocyte	105 000	91 000	150 000–450 000	/µl
SGOT (AST)	84	71	15–37	U/L
SGPT (ALT)	74	61	16–73	U/L
ESR	–	29		mm/hour
PT	–	14.3	11–15	second
INR	–	1.03	0.8–1.2	–
APTT	–	29.7	21–41	second
TIBC	–	373	250–450	µ/dL
HbA1c	6.3	7.8	4.5–6.2	%
IgG anti-HSV-1	–	>34.8	Negative 11	U/mL
MCV – mean corpuscular volume; MCH – mean corpuscular hemoglobin; MCHC – mean corpuscular hemoglobin concentration; RDW-CV – red cell distribution width coefficient of variation; RDW-SD – red cell distribution width standard deviation; SGOT/AST – serum glutamic oxaloacetic transaminase/aspartate aminotransferase; SGPT/ALT – serum glutamic pyruvate transaminase/alanine aminotransferase; ESR – erythrocyte sedimentation rate; PT – prothrombin time; INR – international normalizing ratio; APTT – activated partial thromboplastin time; TIBC – total iron-binding capacity; HbA1c – hemoglobin A1c; IgG HSV-1 – immunoglobulin G for herpes simplex virus-1, – low, H – high, HH – very high.